首页 | 本学科首页   官方微博 | 高级检索  
     

静脉用丙种球蛋白在新生儿ABO溶血症中的应用
引用本文:黄强,王一玲,汤雪晴. 静脉用丙种球蛋白在新生儿ABO溶血症中的应用[J]. 中国康复, 2003, 18(3): 171-172
作者姓名:黄强  王一玲  汤雪晴
作者单位:1. 解放军第465医院,吉林,吉林,132013
2. 解放军第37医院
摘    要:目的 :探讨静脉注射大剂量丙种球蛋白 (IVIG)在治疗新生儿ABO血型不合溶血病中的疗效。方法 :ABO溶血症患儿 90例分为IVIG组 18例与常规组 12例 ,观察IVIG组在使用大剂量IVIG后血清胆红素下降情况。结果 :治疗 2d后评定疗效 ,IVIG组显效 12例 ,有效 5例 ,有效率 88 9% ,对照组显效 5例 ,有效 4例 ,有效率 75 0 % ,2组比较差异有显著性 (P <0 .0 5 )。结论 :大剂量IVIG能有效和快速降低ABO溶血患儿血清胆红素浓度。

关 键 词:静脉 丙种球蛋白 新生儿 ABO溶血症 应用
文章编号:1001-2001(2003)03-0171-02
修稿时间:2002-11-29

Intravenous Injection of Immuneglobulin Therapy for Newborns with ABO Hemolytic Disease
Huang Qiang,Wang Yiling,Tang Xueqing. Intravenous Injection of Immuneglobulin Therapy for Newborns with ABO Hemolytic Disease[J]. Chinese Journal of Rehabilitation, 2003, 18(3): 171-172
Authors:Huang Qiang  Wang Yiling  Tang Xueqing
Affiliation:Huang Qiang,Wang Yiling,Tang Xueqing.Jilin 465 Hospital,Jilin 132013
Abstract:Objective: To evaluate the therapeutic effects of intravenous injection of large doses of immuneglobulin in newborns with ABO hemolytic disease. Methods:Newborns were randomly divided into control group ( n= 12) and immunoglobulin group ( n = 18). Serum bilirubin levels were determined after therapy. Results:The effect of the treatment was assessed after 2 days. In the immunoglobulin group, 12 cases obtained significant effectiveness and 5 effectiveness with the effective rate being 88.9 %, while in the control group 5 cases obtained significant effectiveness and 4 effectiveness with the effective rate being 75 % ( P <0.05). Conclusion:Large dose of immunoglobulin can effectively and rapidly reduce the serum bilirubin of newborns with ABO hemolytic disease.
Keywords:immunoglobulin  ABO hemolytic disease  newborns
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号